In patients with aortic stenosis, increasing levels of sACE2 associated with reduced myocardial ACE2 gene expression and severe myocardial fibrosis is considered as a death risk biomaker (Rajagopal et al., 2010). This evidence concerns the gene ACE2 and Myocardial fibrosis.